Here are three stocks with buy rank and strong value characteristics for investors to consider today, May 20th:
AbbVie Inc. (ABBV - Free Report) : This research-based biopharmaceutical company has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 17.4% over the last 60 days.
AbbVie has a price-to-earnings ratio (P/E) of 8.52, compared with 15.20 for the industry. The company possesses a Value Scoreof A.
United Natural Foods, Inc. (UNFI - Free Report) : This distributor of natural, organic, specialty, produce, and conventional grocery and non-food products has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 64.5% over the last 60 days.
United Natural Foods has a price-to-earnings ratio (P/E) of 6.69, compared with 29.70 for the industry. The company possesses a Value Score of A.
GAIN Capital Holdings, Inc. : This provider of trading services and solutions to the over-the-counter and exchange-traded markets has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising more than 100% over the last 60 days.
GAIN Capital has a price-to-earnings ratio (P/E) of 2.48, compared with 14.40 for the industry. The company possesses a Value Score of B.
See the full list of top ranked stocks here.
Learn more about the Value score and how it is calculated here.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are three stocks with buy rank and strong value characteristics for investors to consider today, May 20th:
AbbVie Inc. (ABBV - Free Report) : This research-based biopharmaceutical company has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 17.4% over the last 60 days.
AbbVie has a price-to-earnings ratio (P/E) of 8.52, compared with 15.20 for the industry. The company possesses a Value Scoreof A.
United Natural Foods, Inc. (UNFI - Free Report) : This distributor of natural, organic, specialty, produce, and conventional grocery and non-food products has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 64.5% over the last 60 days.
United Natural Foods has a price-to-earnings ratio (P/E) of 6.69, compared with 29.70 for the industry. The company possesses a Value Score of A.
GAIN Capital Holdings, Inc. : This provider of trading services and solutions to the over-the-counter and exchange-traded markets has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising more than 100% over the last 60 days.
GAIN Capital has a price-to-earnings ratio (P/E) of 2.48, compared with 14.40 for the industry. The company possesses a Value Score of B.
See the full list of top ranked stocks here.
Learn more about the Value score and how it is calculated here.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on UNFI - FREE
Get the latest research report on ABBV - FREE